Articles from Alpenglow Biosciences

ZEISS and Alpenglow Biosciences today announced a new partnership to jointly develop an inverted light-sheet microscope and bioinformatics pipeline tailored specifically for clinical applications. Alpenglow, a pioneering 3D spatial biology company specializing in open-top light-sheet microscopy, data processing, and AI-driven analysis for biopharma and clinical applications, has partnered with ZEISS, a global leader in light-sheet imaging technologies and visualization software – including ZEISS Lattice Lightsheet 7 and arivis software.

Alpenglow Biosciences is proud to sponsor a featured speaker session and networking lunch at the Society for Investigative Dermatology (SID) 2025 Annual Meeting. Attendees will explore cutting-edge 3D Pathology technologies that are unlocking new insights into skin diseases—including alopecia—and transforming dermatological research and care.

Alpenglow Biosciences is pleased to announce its upcoming Dinner Lecture during the American Association for Cancer Research (AACR) Annual Meeting 2025. The event, titled "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D," is scheduled for April 27, 2025, from 6:00 PM to 9:00 PM at Mercat a la Planxa, 638 South Michigan Avenue, Chicago, IL 60605.​

Alpenglow Biosciences, a pioneer in advanced 3D spatial tissue imaging, the next evolution of static digital pathology, is pleased to announce the appointment of Blandine Merino MS and Mike Rice to its Advisory Board. Their extensive expertise in next-generation sequencing, digital pathology, AI-driven cancer detection, manufacturing, and life science tools will be instrumental in expanding Alpenglow’s impact in precision medicine.

Alpenglow Biosciences, a leader in 3D spatial biology, proudly announces the launch of LUMI, an intuitive user interface designed to integrate smart microscopy into the light-sheet workflow. Attendees of the Association of Biomolecular Resource Facilities (ABRF) 2025 Annual Meeting will get an exclusive first look at LUMI’s capabilities.

Alpenglow Biosciences, a leading 3D spatial biology company, was recently awarded contracts from Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health (NIH) and secured additional investment to further its clinical product development.